Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Crescita Therapeutics
Crescita Reports Second Quarter 2024 Results
August 07, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
July 22, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
July 19, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
July 17, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
June 26, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita to Acquire Strategic Assets of Occy Laboratory
June 20, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 06, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports First Quarter 2024 Results
May 08, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Reports Q4 and Fiscal 2023 Results
March 13, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
August 29, 2023
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Reports Second Quarter 2023 Results
August 09, 2023
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 21, 2023
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
May 12, 2022
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Reports First Quarter 2022 Results
May 11, 2022
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
April 21, 2022
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid
December 15, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®
December 13, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member
November 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC
September 09, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports Second Quarter 2021 Results and Provides Corporate Update
August 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
May 12, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports First Quarter 2021 Results
May 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.